Publications 2011
132.
Mullen W, Gonzalez J, Siwy J, Franke J, Sattar N, Mullan A, Roberts S, Delles C, Mischak H, Albalat A.
A Pilot Study on the Effect of Short-Term Consumption of a Polyphenol Rich Drink on Biomarkers of Coronary Artery Disease Defined by Urinary Proteomics.
J Agric Food Chem. 2011 Dec 28;59(24):12850-7
View Abstract Request Reprint
131.
Jahn H, Wittke S, Zürbig P, Raedler TJ, Arlt S, Kellmann M, Mullen W, Eichenlaub M, Mischak H, Wiedemann K
Peptide fingerprinting of Alzheimer´s disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers
PLoS ONE 2011 Oct; 6(10): e26540
View Abstract Request Reprint
130.
Albalat A, Mischak H, Mullen W.
Clinical application of urinary proteomics/peptidomics.
Expert Rev Proteomics. 2011 Oct;8(5):615-29.
View Abstract Request Reprint
129.
Mullen W, Delles C, Mischak H; members of EuroKUP COST action.
Urinary proteomics in the assessment of chronic kidney disease.
Curr Opin Nephrol Hypertens. 2011 Nov;20(6):654-61.
View Abstract Request Reprint
128.
Mischak H, Thongboonkerd V, Schanstra JP, Vlahou A
Renal and urinary proteomics.
Proteomics Clin Appl. 2011 Jun;5(5-6):211-3. doi: 10.1002/prca.201190031.
View Abstract Request Reprint
127.
Albalat A, Mischak H, Mullen W
Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
Prilozi. 2011 Jul;32(1):13-44.
View Abstract Request Reprint
126.
Kistler AD, Siwy J, Breunig F, Jeevaratnam P, Scherl A, Mullen W, Warnock DG, Wanner C, Hughes DA, Mischak H, Wüthrich RP, Serra AL
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to Enzyme Replacement Therapy
PLoS One. 2011;6(6):e20534. Epub 2011 Jun 15.
View Abstract Request Reprint
125.
Zürbig P, Dihazi H, Metzger J, Thongboonkerd V, Vlahou A
Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.
Proteomics Clin Appl. 2011 Jun;5(5-6):256-68. doi: 10.1002/prca.201000133.
View Abstract Request Reprint
124.
Siwy J, Mullen W, Golovko I, Franke J, Zürbig P
Human urinary peptide database for multiple disease biomarker discovery.
Proteomics Clin Appl. 2011 Jun;5(5-6):367-74. doi: 10.1002/prca.201000155.
View Abstract Request Reprint
123.
Metzger J, Chatzikyrkou C, Broecker V, Schiffer E, Jaensch L, Iphoefer A, Mengel M, Mullen W, Mischak H, Haller H, Gwinner W
Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis
Proteomics Clin Appl. 2011 Jun;5(5-6):322-33. doi: 10.1002/prca.201000153.
View Abstract Request Reprint
122.
Schiffer E, Liabeuf S, Lacroix C, Temmar M, Renard C, Monsarrat B, Choukroun G, Lemke HD, Vanholder R, Mischak H, Massy ZA; on behalf of the European Uremic Toxin Work Group (EUTox).
Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis.
J Hypertens. 2011 Apr;29(4):783-790.
View Abstract Request Reprint
121.
Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W, Franke J, McCulloch JW, North RA, Chappell LC, Mischak H, Poston L, Dominiczak AF, Delles C.
Urinary Proteomics for Prediction of Preeclampsia.
Hypertension. 2011 Mar;57(3):561-9.
View Abstract Request Reprint
120.
Ehrich JH, Schiffer E, Drube J.
Urinary proteomics : The diagnostic key for urinary tract abnormalities and kidney diseases in children?
Urologe A. 2011 Feb;50(2):170-179.
View Abstract Request Reprint
119.
Mayer G, Heinze G, Mischak H, Hellemons ME, Heerspink HJ, Bakker SJ, de Zeeuw D, Haiduk M, Rossing P, Oberbauer R
Omics-bioinformatics in the context of clinical data.
Methods Mol Biol. 2011;719:479-97.
View Abstract Request Reprint
118.
Mischak H, Schanstra JP.
CE-MS in biomarker discovery, validation, and clinical application.
Proteomics Clin Appl. 2011 Feb;5(1-2):9-23. doi: 10.1002/prca.201000058. 11.
View Abstract Request Reprint
117.
Schiffer E
Urinary proteomics: ready for prime time in urological cancer diagnostics?
Personalized Medicine 2011, Jan;8 (1): 81-94.
View Abstract Request Reprint
116.
Siwy J, Vlahou A, Zimmerli LU, Zürbig P, Schiffer E
Clinical proteomics: Current techniques and potential applications in the elderly
Maturitas. 2011 Mar;68(3):233-44
View Abstract Request Reprint
115.
Foucher C, Schiffer E, Mischak H, Ansquer JC, Wilbraham D
Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers
Proteomics Clin Appl. 2011 Apr;5(3-4):159-66. doi: 10.1002/prca.201000076
View Abstract Request Reprint
114.
Lankisch TO, Metzger J, Negm AA, Voßkuhl K, Schiffer E, Siwy J, Weismüller TJ, Andrea S. Schneider AS, Thedieck K, Baumeister R, Zuerbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J
Bile proteomic profiles differentiates cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis
Hepatology. 2011 Mar;53(3):875-884. doi: 10.1002/hep.24103
View Abstract Request Reprint